bluebird bio Inc (NAS:BLUE)
$ 0.4171 0.0121 (2.99%) Market Cap: 81.10 Mil Enterprise Value: 376.50 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 31/100

bluebird bio Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 11, 2021 / 07:50PM GMT
Release Date Price: $32.63 (+3.83%)
Turner Andrew Kufe
JPMorgan Chase & Co, Research Division - Research Analyst

My name is Turner Kufe, and I'm a junior biotech analyst here at JPMorgan. It's my pleasure to introduce Blue's CEO, Nick Leschly. Especially after this morning's news, I'm sure we'll make this a very informative session. So following the presentation, we'll move into Q&A. And remember, everyone is encouraged to ask questions. So feel free to hit that blue button, no pun intended there, or feel free to e-mail me or our IBM, and I confining your questions as best as possible.

So with that, Nick, why don't I hand it over to you for the presentation.

Nick Leschly
bluebird bio, Inc. - President, CEO & Director

Thank you, Turner. I appreciate it, and thank you very much, JPMorgan, for giving us yet again, this opportunity to talk about Blue at this steam conference. There's obviously a lot going on in the world. I'd like to acknowledge extremely troubling events of this past week. And it's very clear that all of us as a global community, have a lot of work to do, and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot